. . . . . . . "[Combined hazard ratios suggested that EZH2 overexpression was associated with poor prognosis of overall survival (OS) (HR?=?1.68, 95% CI: 1.42-1.93) in patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:33+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .